[Special Stock] Panajin Hits Upper Limit on HLB Acquisition News
Panagen surged on news of being acquired by HLB.
As of 11:14 AM on the 22nd, Panagen was trading at 5,790 KRW, hitting the price limit increase of 29.97%.
Hot Picks Today
!["Stock Set to Double: This Company Smiles Every Time a Data Center Is Built [Click e-Stock]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026050416112750184_1777878687.jpg)
"Stock Set to Double: This Company Smiles Every...
- "Is Yours Just Gathering Dust at Home? Millennials & Gen Z Rediscover Digicams O...
- "Continuous Groundwater Pumping Causes Mexico City to Sink 24cm Annually... 'Gia...
- "I Take Full Responsibility"... Seongjae Ahn Issues Direct Apology for 'Wine Swi...
- “She Shouted, ‘The Rope Isn’t Tied!’... Chinese Woman Falls from 168m Cliff ...
Panagen announced that it decided to conduct a third-party allotment paid-in capital increase targeting HLB, an anticancer drug development company, among others, to raise 30 billion KRW in operating funds. HLB's strategy is to expand its business areas not only in anticancer drugs but also in diagnostics through the acquisition of Panagen.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
